Biomarker Technologies | Whitepapers & Reports

Blood Markers of Brain Health: The Simoa® Platform—Measuring CNS biomarkers in serum and plasma with ultrasensitivity

With a sensitivity many times greater than traditional ELISA methods, the Simoa® platform can measure brain biomarkers in blood, offering you another dimension of data from a readily available, non-invasive source.

Advance your knowledge of how biomarkers are propelling research of neurological disorders with Quanterix’s latest brochure, Blood Markers of Brain Health. Download today to learn about Simoa®, the highly sensitive platform that allows for the measurement of brain biomarkers in blood. The technology can detect single molecules bound to individual beads, enabling digital measurements with high precision and sensitivity. Gain a better understanding of neurological conditions with the ability to detect relevant biomarkers earlier in the disease or injury progression and detect multiple biomarkers simultaneously. Researchers can also access all the benefits of the Simoa® platform through the Simoa® Accelerator Laboratory, where trained professionals are ready to assist with your custom assay development needs.